Physician profile
Devin T Mistry
NPI 1508129123
$23,054.31
in general payments reported to CMS, 2019-2025
16 companies · $17K in 2025
The $17K reported for 2025 was more than what 98% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,172 · 2020: $709 · 2021: $1,195 · 2022: $638 · 2023: $1,472 · 2024: $1,043 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $4,385 · Travel and Lodging: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,600.00 |
| Food and Beverage | $4,384.58 |
| Travel and Lodging | $355.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $17,429.50 | 2019-2025 | Scopis Ent, Minifess Blakesley Forceps 45, Latera |
| Medtronic, INC. | $2,324.57 | 2022-2025 | Nim Vital, Propel, Stealthstation S8 Platform |
| Intersect Ent, INC. | $1,741.73 | 2019-2022 | |
| Acclarent, INC | $713.85 | 2019-2024 | Trudi Nav Cable, Relieva Spinplus, Acclarent Aera |
| Integra Lifesciences Corporation | $271.39 | 2024-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Medtronic USA, INC. | $194.94 | 2019-2020 | |
| Preceptis Medical, INC. | $149.07 | 2020-2021 | |
| Aerin Medical INC. | $48.99 | 2019-2020 | |
| Alk-Abello, INC | $48.47 | 2021-2023 | Ragwitek, Odactra, Grastek |
| Olympus America INC. | $32.70 | 2019-2022 | |
| Optinose US, INC. | $32.58 | 2019-2021 | |
| Glaxosmithkline, LLC. | $16.37 | 2021 | |
| Novartis Pharmaceuticals Corporation | $13.97 | 2019 | |
| Genzyme Corporation | $12.55 | 2021 | |
| Karl Storz Endoscopy-America | $12.42 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devin Mistry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.